YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

First big depression advance since Prozac nears FDA approval

Posted online

A drug that's said to be the biggest advance in treating depression since the introduction of Prozac in 1987 is nearing approval by the U.S. Food and Drug Administration.

Johnson & Johnson’s esketamine, a close chemical cousin of the anesthetic ketamine, on Thursday was recommended by a panel of outside experts.

The fast-acting antidepressant is administered through a nasal spray.

Read more from Bloomberg.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences